Hepatitis C virus inhibits CD4 T cell function via binding to Toll-like receptor 7

Dalila Mele, Stefania Mantovani, Barbara Oliviero, Giulia Grossi, Mario U. Mondelli, Stefania Varchetta, Mario U. Mondelli, Serena Ludovisi

Research output: Contribution to journalArticle

Abstract

Toll-like receptor 7 (TLR7) is a ssRNA receptor that activates dendritic cells and macrophages upon ssRNA binding; however, little is known of its role in CD4+ T cells. We show here that hepatitis C virus (HCV) induces a dose dependent inhibition of cytokine production and expression of activation markers in CD4 T cells, which were restored by a TLR7-specific antagonist. These findings indicate that HCV induces CD4 T cell impairment via TLR7 which may contribute to failure of virus eradication, casting doubts on the use of TLR7 agonists to boost innate immunity in chronic RNA virus infections.

Original languageEnglish
Pages (from-to)108-111
Number of pages4
JournalAntiviral Research
Volume137
DOIs
Publication statusPublished - Jan 1 2017

Keywords

  • CD4
  • HCV
  • Imiquimod
  • IRS661
  • TLR7

ASJC Scopus subject areas

  • Pharmacology
  • Virology

Fingerprint Dive into the research topics of 'Hepatitis C virus inhibits CD4 T cell function via binding to Toll-like receptor 7'. Together they form a unique fingerprint.

  • Cite this